Clinic Barcelona Hospital Universitari

Barcelona 08036

0 studies enrolling now · 2 studies all time

What they study most

Antimetabolites, Antineoplastic, Breast Cancer, Breast Tumor, Cancer of the Breast, Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, Endocrine System Diseases, Estrogen Receptor- Negative Breast Cancer, Gemcitabine, HER2- Negative Breast Cancer, Metastatic Breast Cancer

Studies at this site

• Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) — Completed
• Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) — Completed